Literature DB >> 9032345

The role of ATF in regulating the human cytomegalovirus DNA polymerase (UL54) promoter during viral infection.

J A Kerry1, M A Priddy, T L Staley, T R Jones, R M Stenberg.   

Abstract

Previous analysis of the human cytomegalovirus (HCMV) DNA polymerase (UL54) early gene promoter demonstrated that transcriptional activation of this gene is dependent upon the interaction of cellular transcription factors with viral transactivators (J. A. Kerry, M. A. Priddy, T. Y. Jervey, C. P. Kohler, T. L. Staley, C. D. Vanson, T. R. Jones, A. C. Iskenderian, D. G. Anders, and R. M. Stenberg, J. Virol. 70:373-382, 1996). A sequence element, IR1, was shown to be the primary regulatory element of this promoter in transient assays. However, assessment of this element in the context of the viral genome revealed IR1-independent activation at late times after infection. To extend these studies, we aim to identify additional sequence elements involved in the activation of the UL54 promoter. Our present studies demonstrate that the level of binding of proteins to the ATF site in the UL54 promoter is enhanced by viral infection. Furthermore this increase is sensitive to treatment with phosphonoacetic acid (PAA), a DNA synthesis inhibitor. These data suggest that the increase in the level of ATF binding activity is regulated, either directly or indirectly, by HCMV late gene expression. By using specific antibodies, we determined that ATF-1 was a major component of the proteins binding to the UL54 ATF site at late times. In addition, we have demonstrated direct binding of recombinant ATF-1 to the UL54 ATF site. To assess the biological significance of these events, a recombinant virus construct was generated that contained the UL54 promoter with a mutation in the ATF site regulating expression of the chloramphenicol acetyltransferase (CAT) reporter gene inserted between open reading frames US9 and US10. Analysis of this virus (RVATFmCAT) revealed that mutation of the ATF site does not alter the kinetics of UL54 promoter activation. However, levels of CAT mRNA and activity were reduced by 5- to 10-fold compared to those of the wild-type promoter at all stages of infection. These findings indicate that ATF-1 can regulate the levels of UL54 promoter activity at both early and late times. Furthermore, these results imply that HCMV can regulate the activity of cellular factors involved in early gene regulation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9032345      PMCID: PMC191310     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  Identification of sequence elements in the human cytomegalovirus DNA polymerase gene promoter required for activation by viral gene products.

Authors:  J A Kerry; M A Priddy; R M Stenberg
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

2.  Transcription factors RFX1/EF-C and ATF-1 associate with the adenovirus E1A-responsive element of the human proliferating cell nuclear antigen promoter.

Authors:  C Labrie; B H Lee; M B Mathews
Journal:  Nucleic Acids Res       Date:  1995-09-25       Impact factor: 16.971

3.  A molecular mechanism for human T-cell leukemia virus latency and Tax transactivation.

Authors:  A Brauweiler; P Garl; A A Franklin; H A Giebler; J K Nyborg
Journal:  J Biol Chem       Date:  1995-05-26       Impact factor: 5.157

4.  Transactivation by the human cytomegalovirus IE2 86-kilodalton protein requires a domain that binds to both the TATA box-binding protein and the retinoblastoma protein.

Authors:  M H Sommer; A L Scully; D H Spector
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

5.  Analysis and mapping of a family of 3'-coterminal transcripts containing coding sequences for human cytomegalovirus open reading frames UL93 through UL99.

Authors:  B A Wing; E S Huang
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

6.  Cell cycle regulation of cyclin A gene expression by the cyclic AMP-responsive transcription factors CREB and CREM.

Authors:  C Desdouets; G Matesic; C A Molina; N S Foulkes; P Sassone-Corsi; C Brechot; J Sobczak-Thepot
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

7.  The ATF site mediates downregulation of the cyclin A gene during contact inhibition in vascular endothelial cells.

Authors:  M Yoshizumi; C M Hsieh; F Zhou; J C Tsai; C Patterson; M A Perrella; M E Lee
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

8.  Down-regulation of the cyclin A promoter in differentiating human embryonal carcinoma cells is mediated by depletion of ATF-1 and ATF-2 in the complex at the ATF/CRE site.

Authors:  T Nakamura; S Okuyama; S Okamoto; T Nakajima; S Sekiya; K Oda
Journal:  Exp Cell Res       Date:  1995-02       Impact factor: 3.905

9.  Functional interaction between the human cytomegalovirus 86-kilodalton IE2 protein and the cellular transcription factor CREB.

Authors:  D Lang; S Gebert; H Arlt; T Stamminger
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

10.  The human cytomegalovirus UL98 gene transcription unit overlaps with the pp28 true late gene (UL99) and encodes a 58-kilodalton early protein.

Authors:  B L Adam; T Y Jervey; C P Kohler; G L Wright; J A Nelson; R M Stenberg
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

View more
  9 in total

Review 1.  Molecular pathways in virus-induced cytokine production.

Authors:  T H Mogensen; S R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

2.  The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection.

Authors:  A D Yurochko; E S Hwang; L Rasmussen; S Keay; L Pereira; E S Huang
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

3.  Activation of the mitogen-activated protein kinase p38 by human cytomegalovirus infection through two distinct pathways: a novel mechanism for activation of p38.

Authors:  R A Johnson; S M Huong; E S Huang
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Heterologous viral promoters incorporated into the human cytomegalovirus genome are silenced during experimental latency.

Authors:  Qingsong Qin; Rhiannon R Penkert; Robert F Kalejta
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

5.  Transcription factor Sp1 mediates cell-specific trans-activation of the human cytomegalovirus DNA polymerase gene promoter by immediate-early protein IE86 in glioblastoma U373MG cells.

Authors:  J Wu; J O'Neill; M S Barbosa
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

6.  Separate DNA elements containing ATF/CREB and IE86 binding sites differentially regulate the human cytomegalovirus UL112-113 promoter at early and late times in the infection.

Authors:  S M Rodems; C L Clark; D H Spector
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

7.  Transcriptional regulation of the human cytomegalovirus US11 early gene.

Authors:  N H Chau; C D Vanson; J A Kerry
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

8.  Role of the human cytomegalovirus major immediate-early promoter's 19-base-pair-repeat cyclic AMP-response element in acutely infected cells.

Authors:  M J Keller; D G Wheeler; E Cooper; J L Meier
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

9.  Human cytomegalovirus transcriptome activity differs during replication in human fibroblast, epithelial and astrocyte cell lines.

Authors:  James C Towler; Bahram Ebrahimi; Brian Lane; Andrew J Davison; Derrick J Dargan
Journal:  J Gen Virol       Date:  2012-01-18       Impact factor: 3.891

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.